253 related articles for article (PubMed ID: 19101104)
41. Potential role of combined FDG PET/CT & contrast enhancement MRI in a rectal carcinoma model with nodal metastases characterized by a poor FDG-avidity.
Farace P; Conti G; Merigo F; Tambalo S; Marzola P; Sbarbati A; Quarta C; D'Ambrosio D; Chondrogiannis S; Nanni C; Rubello D
Eur J Radiol; 2012 Apr; 81(4):658-62. PubMed ID: 21300505
[TBL] [Abstract][Full Text] [Related]
42. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.
Wartski M; Le Stanc E; Gontier E; Vilain D; Banal A; Tainturier C; Pecking AP; Alberini JL
Nucl Med Commun; 2007 May; 28(5):365-71. PubMed ID: 17414886
[TBL] [Abstract][Full Text] [Related]
43. Complementary roles of whole-body diffusion-weighted MRI and 18F-FDG PET: the state of the art and potential applications.
Kwee TC; Takahara T; Ochiai R; Koh DM; Ohno Y; Nakanishi K; Niwa T; Chenevert TL; Luijten PR; Alavi A
J Nucl Med; 2010 Oct; 51(10):1549-58. PubMed ID: 20847177
[TBL] [Abstract][Full Text] [Related]
44. Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas.
Stéphane V; Samuel B; Vincent D; Joelle G; Remy P; Francois GG; Jean-Pierre T
Eur J Radiol; 2013 Nov; 82(11):2011-7. PubMed ID: 23932096
[TBL] [Abstract][Full Text] [Related]
45. Physiology and pathophysiology of incidental findings detected on FDG-PET scintigraphy.
Liu Y; Ghesani NV; Zuckier LS
Semin Nucl Med; 2010 Jul; 40(4):294-315. PubMed ID: 20513451
[TBL] [Abstract][Full Text] [Related]
46. [The value of PET-CT imaging in malignant tumours of the head and neck].
Balink H; Krabbe CA; de Visscher JG
Ned Tijdschr Geneeskd; 2007 May; 151(21):1167-72. PubMed ID: 17557755
[TBL] [Abstract][Full Text] [Related]
47. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
Menda Y; Graham MM
Semin Nucl Med; 2005 Oct; 35(4):214-9. PubMed ID: 16150243
[TBL] [Abstract][Full Text] [Related]
48. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions.
Nakajo M; Jinnouchi S; Fukukura Y; Tanabe H; Tateno R; Nakajo M
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2088-95. PubMed ID: 17713765
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of head and neck cancer with (18)F-FDG PET: a comparison with conventional methods.
Kresnik E; Mikosch P; Gallowitsch H; Kogler D; Wieser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P
Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 24770459
[TBL] [Abstract][Full Text] [Related]
50. [Clinical evaluation of 18-fluorine fluorodeoxyglucose positron emission tomography-CT imaging in head and neck tumors].
Li XP; Liang Y; Liu X; Wang QS; Wu HB
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):298-301. PubMed ID: 15338869
[TBL] [Abstract][Full Text] [Related]
51. PET/CT in head and neck oncology: State-of-the-art 2013.
Johnson JT; Branstetter BF
Laryngoscope; 2014 Apr; 124(4):913-5. PubMed ID: 24515562
[TBL] [Abstract][Full Text] [Related]
52. Tumors in the tracheobronchial tree: CT and FDG PET features.
Park CM; Goo JM; Lee HJ; Kim MA; Lee CH; Kang MJ
Radiographics; 2009; 29(1):55-71. PubMed ID: 19168836
[TBL] [Abstract][Full Text] [Related]
53. Whole body [(18) F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study.
Bensimhon L; Lavergne T; Hugonnet F; Mainardi JL; Latremouille C; Maunoury C; Lepillier A; Le Heuzey JY; Faraggi M
Clin Microbiol Infect; 2011 Jun; 17(6):836-44. PubMed ID: 20636421
[TBL] [Abstract][Full Text] [Related]
54. Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy.
Ishikita T; Oriuchi N; Higuchi T; Miyashita G; Arisaka Y; Paudyal B; Paudyal P; Hanaoka H; Miyakubo M; Nakasone Y; Negishi A; Yokoo S; Endo K
Ann Nucl Med; 2010 Feb; 24(2):77-82. PubMed ID: 20058105
[TBL] [Abstract][Full Text] [Related]
55. False-positive FDG PET/CT uptake in Warthin tumor in head and neck oncological patients confirmed by a fine needle aspiration.
Klijanienko J; Petras S; De Bosschere L; Paulmier B; Le Tourneau C; Rodriguez J
Diagn Cytopathol; 2012 Mar; 40(3):282-4. PubMed ID: 21591273
[No Abstract] [Full Text] [Related]
56. Estimation of patient dose in (18)F-FDG and (18)F-FDOPA PET/CT examinations.
Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mishra AK; Mondal A; Dwarakanath BS
J Cancer Res Ther; 2013; 9(3):477-83. PubMed ID: 24125986
[TBL] [Abstract][Full Text] [Related]
57. Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.
Kitajima K; Suenaga Y; Sugimura K
Jpn J Radiol; 2015 Dec; 33(12):776-89. PubMed ID: 26507982
[TBL] [Abstract][Full Text] [Related]
58. Methodological aspects of multicenter studies with quantitative PET.
Boellaard R
Methods Mol Biol; 2011; 727():335-49. PubMed ID: 21331942
[TBL] [Abstract][Full Text] [Related]
59. Three synchronous primary tumors with different histology detected by ¹⁸F-FDG PET/CT.
Eren MS; Ozdogan O; Koyuncuoglu M; Degirmenci B
Hell J Nucl Med; 2012; 15(1):56-8. PubMed ID: 22413115
[TBL] [Abstract][Full Text] [Related]
60. Clinical and therapeutic impact of 18F-FDG PET/CT whole-body acquisition including lower limbs in patients with malignant melanoma.
Querellou S; Keromnes N; Abgral R; Sassolas B; Le Roux PY; Cavarec MB; Le Duc-Pennec A; Couturier O; Salaun PY
Nucl Med Commun; 2010 Sep; 31(9):766-72. PubMed ID: 20585271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
